11-89284797-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PS1PM2PP3_StrongPP5_Very_Strong
The NM_000372.5(TYR):c.1209G>T(p.Arg403Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,611,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd.
Frequency
Consequence
NM_000372.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYR | NM_000372.5 | c.1209G>T | p.Arg403Ser | missense_variant | 4/5 | ENST00000263321.6 | NP_000363.1 | |
TYR | XM_011542970.3 | c.1209G>T | p.Arg403Ser | missense_variant | 4/6 | XP_011541272.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYR | ENST00000263321.6 | c.1209G>T | p.Arg403Ser | missense_variant | 4/5 | 1 | NM_000372.5 | ENSP00000263321.4 | ||
TYR | ENST00000528243.1 | n.207G>T | non_coding_transcript_exon_variant | 2/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151736Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250392Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135336
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1459798Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 726270
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151736Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74088
ClinVar
Submissions by phenotype
not provided Pathogenic:3Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 22, 2016 | The R403S variant in the TYR gene has been reported previously in individuals who underwent genetic testing for oculocutaneous albinism type 1 (Opitz et al., 2004; Oetting et al., 1993; Hutton et al., 2008). The R403S variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R403S variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved; however, in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, missense variants in nearby residues (E398V, E398G, W400L, W400C, R402G, R402L, H404N, H404P, R405L, P406L, Q408H) have been reported in the Human Gene Mutation Database in association with oculocutaneous albinism type 1 (Stenson et al., 2014), supporting the functional importance of this region of the protein. The R403S variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded. - |
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 15, 2023 | This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 403 of the TYR protein (p.Arg403Ser). This variant is present in population databases (rs104894316, gnomAD 0.007%). This missense change has been observed in individuals with oculocutaneous albinism (PMID: 1642278, 10987646, 18463683). ClinVar contains an entry for this variant (Variation ID: 3800). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TYR protein function. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2022 | - - |
Tyrosinase-negative oculocutaneous albinism Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 15, 1992 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Oculocutaneous albinism Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 20, 2023 | Variant summary: TYR c.1209G>T (p.Arg403Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 250392 control chromosomes. c.1209G>T has been reported at a compound heterozygous state along with different apparently pathogenic variants in multiple individuals affected with Oculocutaneous Albinism (examples, Tripathi_1992, Passmore_1999, Hutton_2008) . These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 18463683, 10987646, 1642278). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 20, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at